Atlas Trials

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Clinical trial NCT05534646 · RECRUITING

Trial details

NCT number
NCT05534646
Sponsor
Edwin Posadas, MD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Castration-resistant Prostate Cancer
Start date
2023-12-27
Primary completion
2027-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.